Hanlong Zhu

Hanlong Zhu

Auto-generated profile, based on publicly available information

Hanlong Zhu

Medical Centre for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
HZHanlong Zhu
Hanlong Zhu
SZSi Zhao
Si Zhao
RJRuonan Jiao
Ruonan Jiao
JZJian Zhou
Jian Zhou
CZChunmei Zhang
Chunmei Zhang
LMLin Miao
Lin Miao

15 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CZChunmei Zhang
Chunmei Zhang
RTRuiyi Tang
Ruiyi Tang
HZHanlong Zhu
Hanlong Zhu
XGXianxiu Ge
Xianxiu Ge
YWYue Wang
Yue Wang
LMLin Miao
Lin Miao
Treatments for early-onset gastric cancer (EOGC) patients are rarely included in clinical trials, resulting in an unclear impact on survival. This study aimed to investigate the treatment patterns of EOGC patients and their impact on survival. Based on the Surveillance, Epidemiology, and End Results database, we conducted a retrospective analysis of 1639 EOGC patients (< 50 years) diagnosed between 2010 and 2018. Patients with larger tumours, distant metastasis, and AJCC TNM stage in IV were prone to receive nonsurgical treatment. Patients treated with surgery alone had a better prognosis than those receiving SROC or SCRT or nonsurgical treatment. However, analyses stratified by histological type, tumour size and TNM stage showed that patients did not benefit more from SROC and SCRT than from surgery alone. Similar results were observed in the stratified Cox regression risk analysis. Patients who received nonsurgical treatment had the highest risk of overall death [hazard ratio (HR) = 2.443, 95% confidence interval (CI) 1.865–3.200, P < 0.001]. This study indicated that additional radiotherapy, chemotherapy or chemoradiotherapy did not provide a coordinated survival benefit to EOGC patients.

15 March 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
CZChunmei Zhang
Chunmei Zhang
MLMengqi Luo
Mengqi Luo
HZHanlong Zhu
Hanlong Zhu
JZJian Zhou
Jian Zhou
LMLin Miao
Lin Miao
Background: The number of times that an article is cited could reflect its impact. This study aims to recognize and analyze the characteristics of the most frequently cited articles in the field of colorectal diseases. Methods: We identified the 100 most-cited articles using the terms “colorectal,” “colon,” “rectal,” “IBD,” “ulcerative colitis,” “Crohn’s disease,” or “colonoscopy” in Web of Science. The articles were analyzed to evaluate the characteristics, including the number of citations, country of origin, the institution of origin based on the first author’s affiliation, study type, and others. Results: Of the top-cited publications, the number of citations ranged from 1575 to 9283, with a mean of 2504.11 citations. The journal with the greatest number of most-cited articles was the New England Journal of Medicine (n = 23), followed by Science (n = 14) and Nature (n = 12). These papers were published in 14 different countries, of which more than half were from the United States (n = 60). The most popular field was colorectal cancer (n = 45), followed by colon tumors (n = 21). Most of the papers were basic science studies (n = 43) and randomized controlled trials (n = 30). Regarding the level of evidence, there were 5 studies at level I, 29 at level II, and 5, 1, and 15 studies at levels III, IV, and V, respectively. Conclusion: Our study could provide a historical perspective on scientific progress in the field of colorectal diseases. These 100 mostcited articles are of great significance for helping researchers understand this field over time.